The enzyme of enzymes - Nattokinase

Townsend Letter for Doctors and Patients, Nov, 2002 by Nicholas Dr. Calvino

Harrison, H. Berg, L. Berg, D. Polygenic Contributions of Procoagulant Genetic Factors in Chronic Fatigue Syndrome and Related Chronic Illnesses. University of Arizona College of Medicine and HEMEX Laboratories, Phoenix. Arizona., Updated April 17, 2002. Genetics in Medicine, May 2002. (in press).

Hermann Von Wimpffen, H. Pecher. M.O. Enzymes: A drug of the future. Ecomed: AG & Co. www.ecomed.de ISBN: 3-609-51280-6

Lopez. D.A. Willims, R.M. Miehlke, M. Enzymes: The Fountain of Life: Neville Press, me. Charleston, SC. 1994. ISBN: 1-884303-00-5

MacLenna, A. Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis & Rheumatism 46(4):1019-'27, 2002.

Ozawa, K. (1994). Effect of natto bacillus on the intestinal microsystem. In Basic and Clinical Aspects of Japanese Traditional Food Natto, ed. by Sumi, H. Japan Technology Transfer Association. Tokyo. pp. 113-118.

Robbins. K. Sumi, H. Sasaki, K. Toki, N. The transport of high molecular weight human urinary urokinase across the intestinal tract of dogs and human subjects; in Mannucci, A. Urokimase: basic and clinical aspects, pp. 673-74(academic Press. New York 1982).

Sasaki, K. Moriyama, S. Sumi, H. Toki, N. Robbins, K. The transport of 125 I-labeled human high molecular weight urokinase across the intestinal tract in a dog model with stimulation of synthesis and/or release of plasminogen activators. Blood 66:67-75. 1985.

Sasaki, K. Moriyama, S. Sumi, H. Told, N. Robbins, K. The transport of 125 I-labeled human high molecular weight urokinase across the intestinal tract in a dog model with stimulation of synthesis and/or release of plasminogen activators. Blood 66:67-75, 1985.

Sumi, H. Seiki, M. Morimoto, N. Tsushima, H. Maruyama, M. Mihara, H. Plasma fibrinolysis after intraduodenal administration of urokinase in rats. Enzyme 33: 121-127, 1985.

Sumi, H, Sasaki. K. Oral administration of urokinase. 17th Int. Congr. Hematology, Paris, abstr. p.327. 1978.

Sumi, H. Toki, N. Sasaki, K. Robbins, K. Oral administration of urokinase. thrombi. Res. 20:711-714, 1980.

Tinker D, Rucker RB. Role of selected nutrients in synthesis, accumulation, and chemical modification of connective tissue proteins. Physiol Rev 65:607-57, 1985.

Toki, N. Sumi, H. Sasaki, K. Boreisha, I. Robbins, K.C. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins. J. Clin. Invest. 75: 1212-1222, 1985.

Yabe, K., Bull. Coll. Agr. Tokyo Univ. National Federation of Cooperatives on Natto. in: A Historical Record of Natto, p.19. Ed. Food Pionia, Natto Research Center, Tokyo 1977.

Wilkinson, IB. Oral vitamin C reduces arterial Stiffness and platelet aggregation in humans. J Cardiovasc Pharmacol 34(5):690-'3, 1999.

Zeria Pharmaceutical Co., Ltd.: Clinical trial of oral urokinase(not published) New York Liaison Office, 1989.

Sumi. H. Hamada, H. Taushima, H. Mihara, H. A novel fibrinolytic enzyme(nattokinase) in the vegetable cheese natto: A typical and popular soybean food in the Japanese diet. Experimental 43:1110-1111, 1987.